Related Experiment Videos
Human vascular endothelial growth factor cDNA cloning and expression in osteoblasts
1Department of Orthopedics, Xiehe Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022.
Summary
Researchers successfully introduced human vascular endothelial growth factor (VEGF) into rabbit osteoblasts using gene transfer. The study confirmed successful gene expression 72 hours post-transfection.
Area of Science:
- Molecular Biology
- Gene Expression
- Cell Biology
Background:
- Vascular Endothelial Growth Factor (VEGF) plays a crucial role in angiogenesis and tissue repair.
- Understanding VEGF gene expression in osteoblasts is vital for bone regeneration research.
- Efficient gene delivery methods are essential for therapeutic applications in bone healing.
Purpose of the Study:
- To construct a recombinant plasmid carrying human VEGF (hVEGF165).
- To investigate the successful transfection and expression of the human VEGF gene in rabbit osteoblasts.
- To establish a foundation for potential gene therapy approaches in bone regeneration.
Main Methods:
- Amplification of human VEGF cDNA from HL60 cells using nested polymerase chain reaction.
- Construction of the pCD-hVEGF165 recombinant plasmid.
- Lipofection-mediated gene transfer of the plasmid into rabbit osteoblasts.
- Detection of transient gene expression via immunohistochemical analysis.
Main Results:
- Successful construction of the pCD-hVEGF165 recombinant plasmid.
- Demonstrated successful transfection of rabbit osteoblasts with the hVEGF165 plasmid.
- Confirmed distinct expression of the human VEGF gene 72 hours after transfection.
Conclusions:
- The study successfully demonstrated the feasibility of delivering and expressing the human VEGF gene in rabbit osteoblasts.
- Lipofection-mediated gene transfer is an effective method for introducing the hVEGF165 gene into osteoblasts.
- These findings support the potential of VEGF gene therapy for enhancing bone healing and regeneration.